(NVEC) NVE - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US6294452064

NVEC: Sensors, Couplers, Convertors, Magnetoresistive Random Access Memory

NVE Corporation (NASDAQ:NVEC) specializes in the development and commercialization of spintronic devices, leveraging nanotechnology that utilizes electron spin for information processing. The company designs and manufactures a range of spintronic products, including sensors and couplers, which are integral to sensing and data transmission applications. These products serve diverse markets such as factory automation, medical devices, and industrial IoT (IIoT). The companys offerings include standard sensors for detecting magnetic or metallic materials, used in determining position, rotation, or speed in factory automation. Additionally, custom and medical sensors are designed to replace traditional electromechanical magnetic switches in medical devices. NVE also produces spintronic couplers for power conversion and IIoT applications, along with DC-to-DC converters for use in power conversion systems and industrial networks. The company engages in research and development contracts and licenses its spintronic magnetoresistive random access memory (MRAM) technology. NVEs products are distributed through a network of partners. Founded in 1989, the company is headquartered in Eden Prairie, Minnesota.

Over the next three months, NVE Corporations stock is expected to face headwinds. The stock is currently trading below its 20, 50, and 200-day moving averages, signaling bearish momentum. With an average true range (ATR) of 2.86, volatility is moderate, but the downward trend in moving averages suggests limited upside potential. Fundamentally, the companys high P/E ratio of 22.70 and P/B ratio of 5.60 indicate a premium valuation. The P/S ratio of 13.99 further highlights the stocks rich valuation relative to its sales. While the return on equity (RoE) of 23.80% reflects strong profitability, the current market sentiment and technical indicators point to a challenging environment for the stock in the near term. Investors should monitor the companys ability to maintain its profit margins and revenue growth to justify its valuation multiples.

Additional Sources for NVEC Stock

NVEC Stock Overview

Market Cap in USD 365m
Sector Technology
Industry Semiconductors
GiC Sub-Industry Semiconductors
IPO / Inception 1996-09-26

NVEC Stock Ratings

Growth 5y 42.7%
Fundamental 38.4%
Dividend 42.0%
Rel. Strength Industry -18.4
Analysts -
Fair Price Momentum 59.14 USD
Fair Price DCF 51.07 USD

NVEC Dividends

Dividend Yield 12m 5.69%
Yield on Cost 5y 10.65%
Annual Growth 5y 0.00%
Payout Consistency 38.3%

NVEC Growth Ratios

Growth Correlation 3m -74.2%
Growth Correlation 12m -19.2%
Growth Correlation 5y 80.6%
CAGR 5y 11.34%
CAGR/Max DD 5y 0.28
Sharpe Ratio 12m -0.54
Alpha -28.81
Beta 1.27
Volatility 35.44%
Current Volume 17k
Average Volume 20d 20.1k
What is the price of NVEC stocks?
As of March 14, 2025, the stock is trading at USD 64.29 with a total of 16,995 shares traded.
Over the past week, the price has changed by -3.35%, over one month by -11.87%, over three months by -16.43% and over the past year by -19.47%.
Is NVE a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, NVE (NASDAQ:NVEC) is currently (March 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 38.39 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NVEC as of March 2025 is 59.14. This means that NVEC is currently overvalued and has a potential downside of -8.01%.
Is NVEC a buy, sell or hold?
NVE has no consensus analysts rating.
What are the forecast for NVEC stock price target?
According to ValueRays Forecast Model, NVEC NVE will be worth about 67.5 in March 2026. The stock is currently trading at 64.29. This means that the stock has a potential upside of +5.01%.
Issuer Forecast Upside
Wallstreet Target Price 79 22.9%
Analysts Target Price 79 22.9%
ValueRay Target Price 67.5 5%